Globe Life Inc.
Every calculator, already run for GL
Open the full toolkit →You have the numbers on GL. Get the argument.
A written report on which of these readings actually decide the outcome for Globe Life Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
11 analysts covering GLAnalyst Price Target Disagreement for Globe Life Inc.
Wall Street's bull case implies +26% from the current price; the bear case implies -7%. A 33% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
About Globe Life Inc.
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. The company offers whole, term, and other life insurance products, as well as life insurance for children; Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products; and final expense, accidental death, mortgage protection, and hospital insurance products. It sells its products through direct-to-consumer channels,…
GL — frequently asked
Is GL a buy right now?
Wall Street's consensus rating on Globe Life Inc. is Buy across 11 analysts, with a mean price target of $193.91 (+9% vs. the current $177.91). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is GL overvalued?
GL trades at 12.0x trailing earnings, against a DCF fair value of $562 per share. The current price implies -8% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is GL's next earnings date?
Globe Life Inc. is next scheduled to report earnings around Oct 21, 2026. A full GL research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Globe Life Inc.?
Analysts covering Globe Life Inc. (GL) range from a bear-case target of $166.00 to a bull-case high of $225.00, with a mean consensus target of $193.91 across 11 analysts. The spread of $59.00 (33% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Globe Life Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Globe Life Inc.
Start with the evergreen guides that matter most for Financial Services, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full GL research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Globe Life Inc., in minutes. 3 free reports included with every account — no credit card required.